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An exploration of health professionals’ experiences of medicines management in elderly, 
hospitalised patients in Abu Dhabi  
 
Saeed Al Shemeili, Susan Klein, Alison Strath, Saleh Fares, Derek Stewart 
 
Abstract  
Background 
Given the multiplicity of issues relating to medicines in the elderly, the structures and 
processes of medicines management should be clearly defined and described to optimise 
patient outcomes. There is a paucity of research which provides an in-depth exploration of 
these elements of medicines management for elderly patients. 
Objectives 
This study explored health professionals’ experiences of medicines management for elderly, 
hospitalised patients in Abu Dhabi.  
Setting 
The research was conducted in five major hospitals in Abu Dhabi, the United Arab Emirates. 
Method 
Responses to an online sampling questionnaire were used to purposively select nurses, 
pharmacists and physicians for interview. A semi-structured interview schedule was 
developed with reference to Normalization Process Theory (NPT) and the Theoretical 
Domains Framework (TDF) to explore issues of medicines management structures, processes 
and outcomes. Face-to-face interviews of 20-30 minutes were audio-recorded, transcribed 
verbatim and analysed using the Framework Approach. 
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Main Outcome Measures 
Health professionals’ in-depth experiences of structures, processes and outcomes relating to 
medicines management. 
Results 
Saturation of themes was deemed to occur at interview 27 (7 nurses, 13 pharmacists, 7 
physicians). Six key themes and several subthemes emerged from the qualitative analysis, 
which pertained to the need for: appropriate polypharmacy; a systematic approach to 
medicines history taking; improved communication and documentation; improved patients’ 
adherence to medicines; guidelines and policies to support medicines selection, and an 
educated and trained multidisciplinary team. The most dominant TDF behavioural 
determinants were issues around: professional role and identity; beliefs about capabilities; 
beliefs about consequences; environmental context and resources; knowledge, and goals. 
NPT construct identified little evidence of coherence, cognitive participation, collective 
action and reflexive monitoring. 
Conclusion 
The key themes identified in this research indicate the need to develop a more structured 
approach to medicines management in elderly hospitalised patients in Abu Dhabi. The NPT 
constructs and the TDF behavioural determinants can be utilised as part of service 
development and implementing change.  
Impact of findings on practice 
• While nurses, physicians and pharmacists are involved in medicines management in 
elderly, hospitalised patients it is likely that there is a lack of clarity over coherence 
and role definition. 
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• Adopting a theoretical approach to service development could lead to more effective 
interventions 
• Theoretical domains framework of behavioural change can identify individual health 
professional behavioural determinants while normalization process theory can lead to 
more sustained interventions. 
Keywords 
Abu Dhabi, qualitative, interviews, theoretical domains framework, normalization process 
theory 
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Introduction 
Multimorbidity is defined by the World Health Organisation (WHO) as ‘the co-occurrence of 
two or more chronic medical conditions in one person’1, with epidemiological data indicating 
that it increases with age.2,3   
Polypharmacy is considered to be ‘one of the greatest prescribing challenges’, increasing the 
likelihood of adverse drug reactions, drug interactions and contributing to non-adherence.4 
Patterson et al suggest a change in emphasis from inappropriate polypharmacy (prescribing of 
many medicines which are either inappropriate or no longer indicated) to appropriate or 
optimal polypharmacy (appropriate prescribing of many medicines).5  
There is a wealth of evidence of inappropriate polypharmacy in the elderly. United Kingdom 
(UK) data highlight that 20.8% of patients with two clinical conditions are prescribed four to 
nine medicines, and 1.1% prescribed ten or more; in patients with six or more comorbidities, 
values are 47.7% and 41.7 %, respectively.6 Similar statistics have been published for elderly 
residents of nursing homes in the United States (US).7 Furthermore, the elderly are at risk of 
adverse effects due to associated factors of age related physiological changes, impacting 
health outcomes and healthcare resources.8,9  
The appropriate selection, prescribing and review of medicines in the elderly is therefore of 
paramount importance.10 Many tools and frameworks have been developed to promote 
appropriate prescribing. A recent systematic review reported 46 discrete tools to identify 
inappropriate prescribing and high risk drugs.11 The most widely used include Beers Criteria 
in the US and STOPP-START criteria in Europe.12,13  
Multimorbidity and polypharmacy also impact medicines burden, affecting medicines 
adherence. Adherence, redefined as ‘the process by which patients take their medicines as 
prescribed, composed of initiation, implementation and discontinuation’14 is a key issue. Data 
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suggest that between 50 and 80% of those with chronic conditions may be non-adherent, 
depending on the clinical condition being studied. A review of 51 systematic reviews of the 
determinants of adherence identified 771 individual factors, grouped into eight clusters, for 
non-adherence to chronic medicines.15  
Given the multiplicity of issues relating to medicines in the elderly, the structures and 
processes of medicines management should be clearly described to optimise patient 
outcomes. The UK Audit Commission in 2001 stated that medicines management 
‘encompasses the entire way that medicines are selected, procured, delivered, prescribed, 
administered and reviewed to optimise the contribution that medicines make to producing 
informed and desired outcomes of patient care’.16 In 2002, the National Prescribing Centre in 
England (now part of the National Institute for Health and Care Excellence [NICE]) added 
that it ‘considers the systems of processes and behaviours determining how medicines are 
used by patients and the National Health Service (NHS)’. Medicines management has 
primarily been led by pharmacy teams and is the term that has been used historically in the 
NHS for ‘managing people’s medicines’.17  
Very recently, NICE has introduced the term ‘medicines optimisation’ which ‘requires 
evidence-informed decision making about medicines, involving effective patient engagement 
and professional collaboration to provide individualised, patient-centred approach to 
medicines use, within available resources’.18 
Whatever the definition, medicines management in the elderly is complex, requiring clarity 
around healthcare structures and processes in order to achieve the best possible outcomes.  
Donabedian proposed a conceptual model and framework for health services and quality of 
care, describing the elements of structures, processes and outcomes.19 Structures are the 
characteristics of the care delivery setting, including: material resources; human resources; 
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and organisational structure. Processes detail what is actually carried out as part of giving 
care while outcomes describe the patients’ resultant health status.  
Aim of the study 
There is a paucity of research exploring these elements of medicines management for elderly 
patients. The aim of this research was to describe and understand health professionals’ views 
and experiences of medicines management healthcare structures, processes and outcomes for 
elderly, hospitalised patients. Medicines management in this study related to the individual 
patient journey from the point of hospital admission to discharge.  
Ethical approval 
The research was approved by the ethical panel of the School of Pharmacy and Life Sciences 
at Robert Gordon University, UK and the ethical committees of each participating hospital.  
Methods 
Research Design 
A qualitative, interpretative phenomenological methodology of in-depth semi-structured, 
face-to-face interviews with a sample of health professionals most involved in medicines 
management. 
Setting 
The research was conducted in five major hospitals of Abu Dhabi, the United Arab Emirates 
(UAE) providing care for 85% of the population.20 
Sampling and Recruitment  
Purposive sampling was employed, with diversity in profession, countries of practice and 
years of experience. To identify potential participants, all physicians, nurses and pharmacists 
were emailed by the human resources department of each hospital. The email requested those 
working with elderly patients and interested in participating to complete a short online 
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questionnaire. Responses were collated and used to purposively select participants. Those 
selected were contacted by email to arrange a convenient location, date and time of interview. 
Sample Size 
As described by Marshall, the number of subjects required for qualitative research ‘usually 
becomes obvious as the study progresses, as new categories, themes or explanations stop 
emerging from the data (data saturation)’.21  The approach to determining the point of 
saturation described by Francis et al was employed.22 This is described as four principles: an 
initial analysis sample, specifying a priori the sample size at which the first round of analysis 
will be complete; the stopping criterion, specifying a priori how many more interviews will 
be conducted, without new shared themes or ideas emerging, before it can be concluded that 
saturation has been achieved; independent coders; and a clear audit trail of data saturation 
methods.22 
In this study, the initial analysis sample was 15 (five each for physicians, nurses and 
pharmacists) and the stopping criterion was tested after each of two further consecutive 
interviews. Two independent researchers coded the interviews and made comparisons before 
confirming that data saturation had been achieved.  
Data Generation  
The semi-structured interview schedule was developed with reference to Normalization 
Process Theory (NPT) and the Theoretical Domains Framework (TDF). NPT is described as 
a toolkit which focuses on healthcare structures and processes to aid understanding of the 
dynamics of implementing, embedding, and integrating complex interventions.23 The four 
key constructs of NPT are: coherence, the ‘sense-making work’ (e.g. shared understanding); 
cognitive participation, the ‘relational work’ (e.g. defining procedures); collective action, the 
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‘operational work’ (e.g. allocation of work), and reflexive monitoring, the ‘appraisal work’ 
(e.g. determining effectiveness).  
TDF was used to focus on behavioural determinants of individual participants around 
medicines management. It includes constructs from 33 behaviour change theories (e.g. 
Theory of Planned Behavior, Theory of Reasoned Action, Stages of Change Model) and 
proposes that determinants of  behaviour or practice cluster into 14 domains.24 The  most 
relevant domains (e.g. knowledge, beliefs of consequences) were used to guide the interview 
schedule.  
The schedule was reviewed for credibility by members of the research team, which included: 
a leading international pharmacy practice educationalist; a psychologist; a pharmacist with 
strategic development experience, and a leading medical consultant from the UAE.  Pilot 
interviews were conducted with two experienced clinical pharmacy practitioners in the UAE 
based outwith the study settings. All interviews were audio-recorded and transcribed 
verbatim as soon as possible following the interview to allow further refining of the interview 
schedule and consideration of saturation.  
Data Analysis 
The first three interview transcripts were reviewed independently by a member of the 
research team to ensure reliability of transcribing. The Framework Approach to data analysis 
was employed comprising phases of: familiarisation; identifying a thematic framework; 
indexing; charting, and mapping and interpretation.25 Data analysis was undertaken 
independently by another member of the research team, findings compared and consensus 
reached. Emerging themes and subthemes were mapped to NPT and TDF. NVivo software 
10.0 was used as an aid to data management.  
Results 
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Of the 83 respondents to the online questionnaire, 32 agreed to be interviewed, as described 
in Table 1. Saturation of themes was deemed to occur after interviewing 7 nurses, 13 
pharmacists and 7 physicians; six themes and several subthemes emerged.  
 
Theme 1 - Need for appropriate polypharmacy in elderly patients with multimorbidities  
One key theme was the need for appropriate polypharmacy in this patient group. During 
discussion, one pharmacist noted the lack of a clear definition for polypharmacy, 
“Polypharmacy does not have a clear definition…” 
(Pharmacist Z1, Clinical) 
 
Subtheme 1 – Consequences of polypharmacy 
Among the many consequences highlighted were issues of drug interactions, adverse effects 
and poor adherence, 
“…they have polypharmacy - they have a lot of medications. Sometimes the family 
does not know the medications. Multiple medications for same disease or different 
disease that will make it difficult for the patient and the family. Compliance will go 
down usually. Drug-drug interaction will be high. Side effects will be high.” 
(Physician M1, Internist) 
 
Subtheme 2 - Responsibilities for managing polypharmacy 
Some physicians were of the opinion that they dealt with the management and control of their 
specialist condition only, and while this may involve an element of polypharmacy in the use 
of several medicines, they considered polypharmacy to be the responsibility of others. As one 
neurologist described,  
10 
 
 
 
“In my practice, when epilepsy is not controlled I use polypharmacy to kill the 
seizures; we try to stick to the baseline neurologic condition. Polypharmacy, usually it 
is the internist or general medicine physicians who figure that out.” 
(Physician A1, Neurologist) 
 
Several physicians noted the need for specialist and multidisciplinary input, 
“If you have a lot of these issues and you have a problem we need to involve our 
clinical pharmacist with these kind of problems especially for multiple, 
polypharmacy.” 
(Physician A2, ICU) 
 
Many of the pharmacists also considered that they had a clinical role in these patients, 
“I take care, especially the elderly patients with polypharmacy. I review their 
medication profiles, their labs, their vital signs, and I keep the high-risk patient at 
follow-up on daily basis.” 
(Pharmacist K2, Clinical) 
 
However, some also commented that the clinical service currently provided was not always 
sufficient, 
“As much as we can we optimise it, but it is not up to the required standards...We are 
trying to avoid using sedating agents or anticholinergic agents as much as we can, 
but generally speaking it is not up to the required standard.” 
(Pharmacist Z2, Clinical) 
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Subtheme 3 - Need for a systematic approach to a full medicines review  
Several physicians and pharmacists discussed the need for a systematic approach to 
medicines review, 
“These kind of patients they need analysis, meaning you need to analyse their problem 
like system by system, problem by problem.” 
(Physician A2, ICU) 
 
In undertaking the review, the need to discontinue as many medicines as possible was 
highlighted, particularly in the context of patient safety,  
“We try to avoid unnecessary medications, like lot of patients take B complex, which 
has got no significant role to play, so we just cut down those unnecessary 
medications.” 
(Physician K1, GP) 
 
Subtheme 4 - Contribution of healthcare structures and processes to inappropriate 
polypharmacy  
Interviewees considered the UAE healthcare system to be contributing to inappropriate 
polypharmacy. These issues included: individual patients being treated by multiple 
prescribers, sometimes for the same indication; poor documentation; and a lack of inter- and 
intra-professional communication. These aspects were highlighted by a junior physician,  
“….. they shift from one physician to another and nobody explains to them. You know, 
some of the medications have the generic name and different trade names and they 
keep using both, they do not know about it… The problem, many times there is no 
documentation ….” 
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(Physician Z2, Internist) 
 
“I think, physicians when they prescribe they are not checking each other which the 
physician prescribed and he will just come and prescribe and go.” 
(Pharmacist M2, Clinical) 
 
“Sometimes when we are talking with the patient and sometimes they will bring their 
medication. They have two bags of medication which — almost the same generic 
name but different brand name”. 
(Nurse A1) 
 
Theme 2 – Need for systematic approach to medicines history taking 
All interviewees highlighted the need to obtain an accurate, up to date, list of medicines being 
taken at the point of admission to hospital. 
 
Subtheme 1 – Sources of information  
Interviewees described one particular issue of obtaining information from elderly patients  
and the need to use as many sources of information as possible, 
“I try to gather whatever from the online record or record whatever, but still I will 
ask the family to bring it. Because this is very important to know what the patient is 
on, what to continue, what to hold, and later on after discharge … This is again a big 
issue of elderly patients… Sometimes the family does not know the medications.” 
(Physician M1, Internist) 
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Some of the pharmacists noted that it was not always clear who was responsible for 
medicines history taking, 
“Before admission, we have no relation with the patient, but upon admission if we 
receive calls to come to reconcile patients’ medications, we and we reconcile the 
patient’s medications.” 
(Pharmacist Z2, Clinical) 
 
Theme 3 – Need to improve communication and documentation  
Generally, all highlighted the need for more effective and efficient multidisciplinary team 
working, describing issues relating to poor intra- and inter-disciplinary communication and 
documentation.  
 
Subtheme 1 - Lack of communication  
Several physicians stressed the need to improve communication at all levels,  
“… if different specialties have to be involved in dealing with same patient, we have a 
little bit difficulty in coordinating them.”   
(Physician A2, ICU) 
 
Pharmacists also noted issues related to the processes of communicating with physicians. As 
described by one respondent, different modes of communication had been tried and none 
were particularly met their expectations,  
“We are trying verbal communication, also electronic communications, sometimes we 
will put notes on patient’s profile, so the physician can look at it, but we are not 
meeting our expectations with communication.” 
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(Pharmacist K3, Inpatient) 
 
Communication at ward level with the pharmacists was noted to be infrequent,  
“…When it comes to the pharmacists, really we are not dealing with them, except if 
there is something that really needs to be addressed, we will call the pharmacy” 
(Nurse K1) 
Subtheme 2 - Lack of documentation  
There were mixed views on the quality and extent of documentation of medicines in patient 
records, with some physicians repeating the work of others,  
“I look at the medication compared to the system we have in the chart. The problem, 
many times there is no documentation about the medication. Most people write 
documentation. Some don’t write it. Some write incoherent handwriting.” 
(Physician Z2, Internist) 
 
While most of the pharmacists described a systematic approach to review of patients’ 
medicines and documentation of issues,  
“I go through their medication charts and the labs, and vital signs and if there is 
some feedback, I always give the feedback in verbal and in addition I give my 
medication review also in the patient chart documentation.” 
(Pharmacist K2, Clinical) 
 
several admitted that they did not always record any identified issues,   
“…be honest, sometimes I forget to document like, I forget to document on daily 
basis, so sometimes there are something that I forget to document.” 
15 
 
 
 
(Pharmacist T1, Clinical) 
 
Theme 4 – Need to improve patients’ adherence to medicines 
The issues of non-adherence of elderly patients were discussed at length. 
 
Subtheme 1 – Non-adherence as a consequence of multimorbidities and polypharmacy 
Several shared similar views of the links between multimorbidities, polypharmacy and 
adherence, 
“The poor adherence is more frequent compared to overdosing or extra doses taken 
and the poor adherence I think, the polypharmacy is number one factor for this.“  
(Pharmacist K1, Clinical) 
 
Subtheme 2 – Patients’ lack of knowledge   
Physicians, nurses and pharmacists described issues related to patients’ knowledge leading to 
non-adherence, 
“Many patients who have been given medication, after about few months they feel 
comfortable and normally they think why do I am taking this medication. So they start 
reducing their own and sometimes they stop also. Once we crosscheck, patient says 
nobody told me that this medication I have to take lifelong.” 
(Physician K1, GP) 
 
Subtheme 3 – Need for patient/carer/family counselling  
16 
 
 
 
While all described at length the need for and importance of counselling elderly patients and 
their carers/family, it appeared that this tended to take place only at the point of discharge 
from hospital.  A range of professionals were involved as described by one pharmacist, 
“First of all, it is the responsibilities for the physician to tell the patient that he is 
upon discharge and he will tell him what kind of medications he will take. On our part 
as pharmacists, we do the patient counselling and when we dispense medications, 
give the patient counselling.” 
(Pharmacist K3, Inpatient) 
 
In some instances, the input of pharmacist was targeted at patients prescribed high risk 
medicines, 
“There is a program for counselling the patient on select drugs, which have been 
identified as either high-alert high-risk medications.” 
(Pharmacist M1, Clinical) 
 
None of the interviewees described the need to educate and counsel patients at several points 
during stay, or the need to focus on aspects other than impacting knowledge. 
 
Theme 5 - Need for guidelines and policies to support medicines selection 
Several raised aspects such as a standardised approach of policies and guidance to support 
medicines selection in this population of patients.  
 
Subtheme 1 - Awareness of and adherence to guidelines and policies  
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There were diverse views on organisational and clinician approaches to medicines selection. 
Two pharmacists gave detailed accounts of the organisational level approaches in their 
hospitals, comprising Pharmacy and Therapeutic Committees which aimed to provide 
recommendations on preferred medicines to medical staff, 
“Physicians in our hospital they cannot prescribe whatever they want to prescribe. 
We have here what is called ‘pharmacy & therapeutic committee’, generates a list for 
our hospital and this pharmacy and therapeutic committee is a multidisciplinary 
team.” 
(Pharmacist A2, Clinical) 
 
One pharmacist, however, noted that the process of medicines selection was less controlled at 
the individual physician level,  
 “Most of our physicians are basically free to prescribe whatever they want.” 
(Pharmacist T1, Clinical) 
 
One physician expressed his frustration in the lack of freedom to prescribe any medicine,  
“The problem is a lot of times we do not get the drugs that we want. If I give them this 
antibiotic and they have to jump through a lot of hoops to get the medication, are they 
really going to end up getting it?” 
(Physician Z1, Internist) 
 
There was also a notable lack of use of guidelines and policies to support medicines choice 
and that selection was normally at the discretion of the physician, but acknowledging that 
specific clinical guidelines may be referred to,   
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“It is like physician discretion rather than based on any guideline, but we rely on like 
international guidelines such as for epilepsy, American Heart Association in Stroke 
and then we have other guidelines for so many other things.” 
(Physician A1, Neurologist) 
 
Some physicians were of the view that there was a need for the development and 
implementation of guidelines for elderly patients,   
“Elderly – we try to establish guidelines. I think we are a little bit behind. We should 
do even better. There are some policies in the hospital where we follow, but I think we 
should do better, definitely.” 
(Physician M1, Internist) 
 
When asked specifically about their awareness and use of any lists of drugs potentially 
inappropriate in the elderly or drugs commonly omitted in the elderly, only one pharmacist 
was aware of Beers Criteria and admitted not using routinely,  
“Yes, sometimes. Yeah. It is not always the case, but sometimes I use this list and first 
I got through the idea of this list in 2011 when I was doing research from my 
pharmacotherapy, so I found this article in annual of pharmacotherapy, the Beers 
Criteria, and I shared with other colleagues for some patients it is useful and 
helpful.” 
(Pharmacist K2, Clinical) 
Notably, none of the nurses gave detailed responses in relation to questions on medicines 
selection. 
 
19 
 
 
 
Theme 6 - Need for an educated and trained multidisciplinary team  
Another key theme was the need for a focused education and training programme for health 
professionals to optimise all aspect of medicines management. 
 
Subtheme 1 - Need for specialised education and training 
Physicians, nurses and pharmacists proposed that there was an inherent need for specialised 
education and training in medicines management for elderly patients, highlighting several 
issues including medicines selection.  
 
Several physicians stated that they need specific training on elderly medication. 
“You need to have training, because like paediatrics, geriatric population needs 
specific involvement. Even the pharmacokinetics is different like the paediatrics.” 
(Physician A2, ICU) 
 
“Their doses are different and we cannot give someone adult the same dose like 
young or whatever. They have different way of approaching things and drug 
interaction in the elderly is a little bit different.” 
(Physician Z2, Internist) 
“It is better you have to have a special geriatric nurse for geriatric patients. It is 
better.” 
(Nurse K1) 
Table 2 provides a summary of the themes and subthemes. These are mapped to TDF 
domains (Table 3) and NPT constructs (Table 4).  
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Discussion 
This research highlights health professionals’ perceptions of the need for: appropriate 
polypharmacy; a systematic approach to medicines history taking; improved communication 
and documentation; improved patients’ adherence to medicines; guidelines and policies to 
support medicines selection; and an educated and trained multidisciplinary team. Findings are 
underpinned by two theoretical frameworks. The TDF was used in relation to domains of 
determinants of behaviour at the individual practitioner level. The domains which were most 
dominant were: professional role and identity; beliefs about capabilities; beliefs about 
consequences; environmental context and resources; knowledge, and goals. NPT was used at 
the organisational level with little evidence of coherence, cognitive participation, collective 
action and reflexive monitoring. 
There are a number of strengths to this study. To date, while several studies have used a 
qualitative approach to research aspects of medicines management (e.g. medicines selection 
and prescribing)26-28 there is an absence of published qualitative studies relating to the full 
spectrum of medicines management activities as described in this paper. Throughout this 
qualitative study, attention was paid to aspects of research trustworthiness with consideration 
of credibility, transferability and dependability.  
There are, however, several limitations hence the findings should be interpreted with caution. 
The research was limited to five major hospitals; although qualitative findings do not seek to 
be generalizable, the research was conducted within Abu Dhabi only and hence the research 
findings may not be transferrable to other hospitals in Abu Dhabi, the other six Emirates 
within the UAE, the Middle East and beyond. 
Interviewees described the need for guidelines to support medicines selection and review. 
While there is an array of international clinical guidelines which could be adapted for the 
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Middle East, the failure of single disease state guidelines to account for patients with 
multimorbidities has been highlighted by others.29,30  
Several other qualitative studies have focused on elements of medicines management 
processes. Vogelsmeier et al identified the need for more efficient deployment of staff in 
processes of medicines reconciliation while Skoglund et al highlighted that prescribing 
practice was pragmatic rather than evidence-based medicine.26,27 Cullinan et al stressed the 
lack of emphasis on geriatric clinical pharmacotherapy in physicians’ undergraduate courses 
and the need to consider social influences on prescribing decision making.28 Our findings are 
similar in relation to the need for: a systematic approach to medicines history taking; 
appropriate polypharmacy; improved communication and documentation; and guidelines and 
policies to support medicines selection.   
Our NPT findings highlight a perceived lack of coherence with little shared beliefs around the 
aims of medicines management, defining appropriate polypharmacy, and approaches to 
promote appropriate polypharmacy. However, there was clear knowledge of the implications 
and consequences of inappropriate polypharmacy. In terms of the other NPT constructs, there 
was little evidence of cognitive participation and collective action with no clear allocation of 
the processes of medicines reconciliation, history taking and counselling. While medicines 
selection was clearly the remit of the physicians, there was confusion relating to multiple 
prescribers prescribing for the same indication, and responsibility for medicines review. 
There is a need for considering task allocation with clearly defined roles and responsibilities, 
requiring improved standards for documentation and inter- and intra-professional 
communication.  There is opportunity to promote reflexive monitoring to evaluate the 
outcomes of the processes, which will require agreeing clear service aims and objectives, all 
of which must centre on optimising patient outcomes.  
22 
 
 
 
There is a consensus in the literature that behaviour change is key to increasing the uptake of 
evidence into healthcare practice.31 Implementing behaviour-change interventions 
commences with problem analysis, which is informed by theory. The NPT constructs and the 
TDF behavioural determinants have provided a theoretical approach to identifying the 
behaviour determinants in relation to medicines management. Further research is required 
using consensus based approaches and expert panels to define practice norms of structures, 
processes and desired outcomes. 
Conclusion 
Health professionals perceived deficiencies in structures and processes of medicines 
management in elderly hospitalized patients. These issues were at both an individual and 
organisational levels. Key areas of behavioural theories were identified for targeting of 
interventions.  
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Tables 
Table 1 Demographics of those agreeing to be interviewed (n=32) 
Profession 
     Physician 
     Nurse 
     Pharmacist 
% (n) 
28.1 (9) 
25.0 (8) 
46.9 (15) 
Years of experience 
     1-5 
     6-10 
     11-15      
     16-20 
     21-25 
     26-30 
     >30 
 
 
18.8 (6) 
32.3 (10) 
9.4 (3) 
21.9 (7) 
9.4 (3) 
6.3 (2) 
3.1 (1) 
Countries of training 
     UAE 
     Other Middle East 
     Asia 
     USA 
     Europe 
     Africa 
 
 
25.0 (8) 
43.8 (6) 
21.9 (7) 
15.6 (5) 
12.5 (4) 
6.3 (2) 
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Table 2 A summary of key themes and subthemes 
Key Themes Subthemes 
Theme 1  
 
Need for appropriate 
polypharmacy in elderly 
patients with multimorbidities  
 
Subtheme 1 - Consequences of polypharmacy 
Subtheme 2 - Responsibilities for managing 
polypharmacy 
Subtheme 3 - Need for a systematic approach to a 
full medicines review  
Subtheme 4 - Contribution of healthcare structures 
and processes to inappropriate polypharmacy  
Theme 2 
Need for systematic approach 
to medicines history taking 
Subtheme 1 - Sources of information  
 
Theme 3 
Need to improve 
communication and 
documentation  
Subtheme 1 - Lack of communication  
 
Subtheme 2 - Lack of documentation  
Theme 4 
Need to improve patients’ 
adherence to medicines 
Subtheme 1 - Non-adherence as a consequence of 
multimorbidities and polypharmacy 
 
Subtheme 2 - patients’ lack of knowledge   
 
Subtheme 3 - Need for patient/carer/family 
counselling  
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Theme 5 
Need for guidelines and 
policies to support medicines 
selection 
Subtheme 1 - Awareness of and adherence to 
guidelines and policies  
 
Theme 6 
 
Need for an educated and 
trained multidisciplinary team  
Subtheme 1 - Need for specialised education and 
training 
  
 
Table 3 Themes and subthemes mapped to TDF domains 
Theoretical Domains Framework 
Domains Themes & Subthemes 
Professional 
role & identity  
(Coherent set of 
behaviors and 
displayed 
personal 
qualities of an 
individual in a 
social or work 
setting) 
Several subthemes mapped to the domain of professional role and 
identity. Most notably, interviewees expressed diverse views around 
roles and responsibilities in managing polypharmacy from those 
physicians who viewed that their remit was solely around managing 
the conditions within the specialist field of practice to those more 
concerned with polypharmacy (Theme 1, Subtheme 2). Other similar 
themes were around less clearly defined roles and responsibilities in 
medicines history taking (Theme 2, Subtheme 1), 
patient/carer/family counselling (Theme 4, Subtheme 3), medicines 
selection (Theme 5, Subtheme 1) and optimising medicine 
management for elderly patients (Theme 6, Subtheme 1). 
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Beliefs about 
capabilities 
(Acceptance of 
the truth, 
reality, or 
validity about 
an ability, 
talent, or 
facility that a 
person can put 
into 
constructive 
use) 
While not explicitly discussing beliefs about their individual 
capabilities regarding the different aspects of medicines 
management, the interviewees emphasised the need for specialised 
education and training in medicines management for elderly 
patients, highlighting particularly the complexities of medicines 
selection (Theme 6, Subtheme 1). 
Beliefs about 
consequences 
(Acceptance of 
the truth, 
reality, or 
validity about 
the outcomes of 
a behavior in a 
given situation) 
Several respondents highlighted the consequences of polypharmacy 
in terms of drug interactions, the occurrence of adverse effects and 
poor patient medicines adherence (Theme 1, Subtheme 1). 
Awareness of these consequences appeared to influence behaviors of 
some interviewees in relation to their practices of conducting full 
medicines reviews in elderly patients (Theme 1, Subtheme 3). 
Several interviewees described that the consequences of their 
experiences of cognitive impairment and confusion in elderly 
patients resulted in them using several sources of information 
(including family members and carers) to ensure as complete a 
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medicines history as possible (Theme 2, Subtheme 1) 
All interviews demonstrated their awareness of the heightened issue 
of non-adherence in elderly patients due to inappropriate 
polypharmacy (Theme 4, Subtheme 1), patients’ lack of medicines 
knowledge  (Theme 4, Subtheme 2) all of which impacted their 
behaviors relating to medicines counselling (Theme 4, Subtheme 3).  
Environmental 
context and 
resources 
(Circumstances 
of a person’ s 
situation or 
environment 
that 
discourages or 
encourages the 
development of 
skills and 
abilities, 
independence, 
social 
competence, 
and adaptive 
Several themes and subthemes mapped to domain of environmental 
context and resources and how these affected behaviors of 
individuals. Many interviewees commented on the issue of 
individual patients being treated by multiple prescribers, sometimes 
for the same indication, and the problem of poor documentation 
(Theme 3, Subtheme 2); and a general lack of inter- and intra-
professional communication (Theme 3, Subtheme 1). As a result 
physicians, nurses and pharmacists considered the healthcare system 
to be contributing to inappropriate polypharmacy (Theme 1, 
Subtheme 4). 
Several physicians and pharmacists were of the view that more 
standardised approach to the development and use of policies and 
guidance to support medicines selection would be of benefit (Theme 
5, Subtheme 1). 
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Table 4 Themes and subthemes mapped to the four constructs of NPT 
Normalisation Process Theory 
behavior) 
Knowledge 
(An awareness 
of the existence 
of something)  
Interviewees expressed diverse views around their awareness of 
polypharmacy and its association with interactions, adverse drug 
reactions, and impacting patient medicines adherence (Theme 1, 
Subtheme 1). 
While some interviewees were aware of the existence of 
international guidelines to support their prescribing in the elderly, 
there was a major gap in knowledge specific tools such as Beers, 
STOPP/START to aid appropriate prescribing and identify 
inappropriate prescribing in the in elderly (Theme 5, Subtheme 1). 
Goals 
(Mental 
representations 
of outcomes 
that an 
individual 
wants to 
achieve) 
Several of the themes and subthemes map to the domain of goals, 
particularly around the need for appropriate polypharmacy (Theme 
1), need for a systematic approach to medicines history taking 
(Theme 2) and need to improve patient adherence (Theme 4).  
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Constructs  Themes & Subthemes 
Coherence 
Defines and organises 
the components of a 
practice  
While respondents appeared to be aware of the different 
processes in relation to medicines management in elderly 
hospitalized patients (i.e. medicines history taking, 
reconciliation, medicines selection, counselling etc.), there 
appeared to be less coherence around actually defining these 
processes and demonstrating consistent, shared beliefs in a 
structured manner. For example, all were aware of the 
consequences of polypharmacy (Theme 1, Subtheme 1) but 
there were varied responses to defining appropriate 
polypharmacy (Theme 1, Subtheme 2). Also there were 
varied responses in terms of the approach to a full medicines 
review (Theme 1, Subtheme 3). There was more coherence 
around the goals of patient counselling in relation to 
medicines adherence (Theme 4, Subtheme 3).  
Cognitive 
participation 
Defined and organises 
the people implicated 
in a complex 
intervention and brings 
a practice into practice, 
organising ways that 
There were diverse views around task allocation in relation 
to the different elements on medicines management in 
elderly hospitalized patients. Specific responsibilities and 
roles around managing polypharmacy were unclear (Theme 
1, Subtheme 2), as were those relating to conducting 
medicines reviews (Theme 1, Subtheme 3).  For example, on 
occasions pharmacists were involved in processes of 
medicines reconciliation, but this did not appear to be a 
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people join and support 
a practice 
clearly allocated task (Theme 2).  
It appeared that physicians, nurses and pharmacists were all 
involved in patient medicines counselling with no clearly 
defined remit assigned to each profession (Theme 4, 
Subtheme 3) 
However, all interviewees were aware of the need to 
undertake education and training in relation to medicines 
management in elderly hospitalized patients (Theme 6, 
Subtheme 1) 
Collective action  
Defines and organising 
the enacting of a 
practice through skill 
set and task allocation, 
and performance with 
accountability and 
interconnected work 
This mechanism related to the actual work or skills involved 
in delivering the tasks relating to medicines management.  
The actual approach to medicines review varied amongst 
physicians in different specialties and between different 
professions such as pharmacists and nurses (Theme 1, 
Subtheme 3). All those involved in medicines history taking 
described the use of multiple sources in an attempt to gather 
as much information as possible (Theme 2, Subtheme 1). 
Interviewees were aware of the suboptimal inter- and intra-
professional communication (Theme 3, Subtheme 1) and 
documentation (Theme 3, Subtheme 2).  
All discussed the need to counsel the family and carers in 
addition to (and sometimes instead of) the patient (Theme 4, 
Subtheme 3). There were diverse descriptions of the use of 
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policies and guidelines in relation to medicines selection 
(Theme 5, Subtheme 1).  
Reflexive monitoring 
Defines and organises 
assessment of the 
outcomes of a practice 
in terms of effects, 
communal and 
individual appraisal 
There was very little description or discussion of how the 
patient outcomes of the processes of medicines management 
were assessed, either at individual patient or population 
levels. However, many expressed the need of a 
multidisciplinary team approach for better medicines review 
(Theme 1, Subtheme 3) and for specialised education and to 
optimise patient outcomes (Theme 6, Subtheme 1).  
 
 
 
 
